Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis
Tricco AC, Strifler L, Veroniki AA, Yazdi F, Khan PA, Scott A, Ng C, Antony J, Mrklas K, D’Souza J, Cardoso R, Straus SE. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open. 2015 Oct 26;5(10):e009183. doi: 10.1136/bmjopen-2015-009183.
[sidebar] Commissioned and Funded by: Ontario Drug Policy Research Network (ODPRN) and Ontario Ministry of Health and Long-Term Care (OMHLTC)
[/no-bottom-margin]
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Our results can be used by patients and physicians to tailor administration of these agents
- Commissioned by the Ontario Drug Policy Research Network to inform the listing of these agents by the Ontario Public Drug Program
- Many inhaled agents are available for chronic obstructive pulmonary disease (COPD), some are safer and more effective than others
Altmetrics:
Related Projects:
[/sidebar-content]Category : KS Projects
Date : 03 Sep 2020